Europe — EMA

Ogsiveo (Nirogacestat Hydrobromide)

Request sourcing

Pack/s

What is Nirogacestat Hydrobromide?

Nirogacestat, the active ingredient in Ogsiveo, is a gamma‑secretase inhibitor presented as a for oral use. It is being investigated for the treatment of rare bone tumors and related conditions in adult patients. GNH USA supplies Ogsiveo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Ogsiveo as a licensed, GDP‑compliant international pharmaceutical ...

What is Nirogacestat Hydrobromide used for?

Ogsivev

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →

Product details

Drug

Nirogacestat Hydrobromide

Route

Oral Use

Manufacturer

Springworks Therapeutics Ireland Limited

Origin